Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

2.

Factors associated with duloxetine treatment among patients with major depressive disorder in Veterans Health Administration: a retrospective study.

Shi L, Liu J, Campbell C, Zhao Y.

Curr Med Res Opin. 2010 Dec;26(12):2715-21. doi: 10.1185/03007995.2010.530140.

PMID:
20973616
3.

Predictors of duloxetine versus other treatments among veterans with diabetic peripheral neuropathic pain: a retrospective study.

Zhao Y, Liu J, Zhao Y, Thethi T, Fonseca V, Shi L.

Pain Pract. 2012 Jun;12(5):366-73. doi: 10.1111/j.1533-2500.2011.00494.x.

PMID:
21951753
4.

Efficacy and safety of duloxetine 60 mg once daily in the treatment of pain in patients with major depressive disorder and at least moderate pain of unknown etiology: a randomized controlled trial.

Brecht S, Courtecuisse C, Debieuvre C, Croenlein J, Desaiah D, Raskin J, Petit C, Demyttenaere K.

J Clin Psychiatry. 2007 Nov;68(11):1707-16.

PMID:
18052564
5.

A randomized placebo-controlled trial of duloxetine in patients with major depressive disorder and associated painful physical symptoms.

Gaynor PJ, Gopal M, Zheng W, Martinez JM, Robinson MJ, Marangell LB.

Curr Med Res Opin. 2011 Oct;27(10):1849-58. doi: 10.1185/03007995.2011.609539.

PMID:
21838411
6.

Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder.

Brannan SK, Mallinckrodt CH, Brown EB, Wohlreich MM, Watkin JG, Schatzberg AF.

J Psychiatr Res. 2005 Jan;39(1):43-53.

PMID:
15504423
7.

Duloxetine versus placebo in the treatment of major depressive disorder and associated painful physical symptoms: a replication study.

Gaynor PJ, Gopal M, Zheng W, Martinez JM, Robinson MJ, Hann D, Marangell LB.

Curr Med Res Opin. 2011 Oct;27(10):1859-67. doi: 10.1185/03007995.2011.609540.

PMID:
21838410
8.

Utilization of duloxetine and celecoxib in osteoarthritis patients.

Peng X, Wu N, Chen SY, Yu X, Andrews JS, Novick D.

Curr Med Res Opin. 2013 Sep;29(9):1161-9. doi: 10.1185/03007995.2013.816275.

PMID:
23777314
9.

Treatment patterns associated with Duloxetine and Venlafaxine use for Major Depressive Disorder.

Ye W, Zhao Y, Robinson RL, Swindle RW.

BMC Psychiatry. 2011 Jan 31;11:19. doi: 10.1186/1471-244X-11-19.

10.

Medication adherence and healthcare costs among patients with diabetic peripheral neuropathic pain initiating duloxetine versus pregabalin.

Zhao Y, Sun P, Watson P.

Curr Med Res Opin. 2011 Apr;27(4):785-92. doi: 10.1185/03007995.2011.554807.

PMID:
21303196
11.

Trajectory analysis of healthcare costs for patients with major depressive disorder treated with high doses of duloxetine.

Cui Z, Faries DE, Zhao Y, Novick D, Liu X.

J Med Econ. 2011;14(5):662-72. doi: 10.3111/13696998.2011.611060.

PMID:
21892857
12.

A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder.

Arnold LM, Rosen A, Pritchett YL, D'Souza DN, Goldstein DJ, Iyengar S, Wernicke JF.

Pain. 2005 Dec 15;119(1-3):5-15.

PMID:
16298061
13.

Double-blind comparison of escitalopram and duloxetine in the acute treatment of major depressive disorder.

Khan A, Bose A, Alexopoulos GS, Gommoll C, Li D, Gandhi C.

Clin Drug Investig. 2007;27(7):481-92.

PMID:
17563128
14.

Predictors of pain medication selection among patients diagnosed with fibromyalgia.

Boulanger L, Wu N, Chen SY, Nagar S, Fraser K, Bernauer MJ, Zhao Z, Zhao Y.

Pain Pract. 2012 Apr;12(4):266-75. doi: 10.1111/j.1533-2500.2011.00497.x.

PMID:
21899718
15.

Incidence and duration of antidepressant-induced nausea: duloxetine compared with paroxetine and fluoxetine.

Greist J, McNamara RK, Mallinckrodt CH, Rayamajhi JN, Raskin J.

Clin Ther. 2004 Sep;26(9):1446-55.

PMID:
15531007
16.
17.

An open-label study of duloxetine for the treatment of major depressive disorder: comparison of switching versus initiating treatment approaches.

Wohlreich MM, Martinez JM, Mallinckrodt CH, Prakash A, Watkin JG, Fava M.

J Clin Psychopharmacol. 2005 Dec;25(6):552-60.

PMID:
16282837
18.

Early discontinuation and suboptimal dosing of duloxetine treatment in patients with major depressive disorder: analysis from a US third-party payer perspective.

Cui Z, Faries DE, Gelwicks S, Novick D, Liu X.

J Med Econ. 2012;15(1):134-44. doi: 10.3111/13696998.2011.632043.

PMID:
22014076
19.

Adherence and persistence with duloxetine and hospital utilization in patients with major depressive disorder.

Liu X, Tepper PG, Able SL.

Int Clin Psychopharmacol. 2011 May;26(3):173-80. doi: 10.1097/YIC.0b013e328343ba1e.

PMID:
21278576
20.

Duloxetine use in chronic low back pain: treatment patterns and costs.

Ivanova JI, Birnbaum HG, Kantor E, Schiller M, Swindle RW.

Pharmacoeconomics. 2012 Jul 1;30(7):595-609. doi: 10.2165/11598130-000000000-00000.

PMID:
22686662
Items per page

Supplemental Content

Support Center